A 58-year-old woman presented with a 6-month history of progressive dysesthesias and weakness involving her hands as well as ambulatory dysfunction. She described a diffuse "tight band" of pain around her upper abdomen. There was no bladder dysfunction. Her history revealed systemic scleroderma diagnosed in 2001 characterized by Raynaud phenomenon, esophageal dysmotility, pulmonary involvement resulting in pulmonary hypertension, and calcinosis cutis. There was no history of trauma or intervertebral disc disease. She was on immunosuppression with methotrexate and mycophenolate. Pulmonary hypertension was treated with bosentan.
Section 2
The patient's neurologic syndrome (symmetric dysesthesias in both arms as well as the lower trunk, weakness in the forearms and hands, and spastic gait abnormality) suggested a cervical myelopathy. Based on absence of pain and the slowly progressive nature of the disease accompanied by decreased mobility, the main differential diagnostic considerations included extrinsic compression by degenerative changes such as a centrally herniated disc or an intrinsic spinal cord process such as a low-grade neoplasm or inflammatory process.
A cervical spine MRI with contrast was obtained and revealed a well-demarcated, T1-and T2-hypointense mass without enhancement. This lesion involved the soft tissues posterior to the spinal canal and was predominantly localized at C4. At this level, spinal canal stenosis with near obliteration of the CSF space as well as an intrinsic spinal cord signal abnormality was demonstrated (figure 1, A-C and E). A CT angiogram was ordered for further characterization of the mass and its relationship to the cervical vasculature. Based on CT characteristics, the cervical mass lesion was composed of a bony matrix. It involved the posterior elements of C4/5, expanded the transverse processes, laminae, and spinous processes, and encroached upon the right C4 foramen transversarium, causing mild mass effect on the vertebral artery ( figure 1E) . A skull to thigh 18 F-FDG PET/CT failed to reveal metabolic activity within the mass ( figure 1D ). 
Section 3
Lack of metabolic activity as demonstrated on PET/CT narrowed the differential diagnosis to fibrous dysplasia or a benign primary osteogenic tumor such as osteoblastoma. 1 Given the patient's history of systemic scleroderma, diffuse calcinosis of the neck was also considered. Fine-needle aspiration cytology revealed necrotic tissue with calcifications. Subsequently, the patient was taken to the operating room for C4-6 laminectomy, tumor removal, and C2-T1 fusion. The excised tumor was composed of dense regular fibroconnective tissue with focal necrosis and multiple deposits of calcium hydroxyapatite consistent with calcinosis ( figure 1H ). The patient was seen for follow-up 6 months after surgery with no evidence of residual or recurrent mass on a surveillance MRI of the cervical spine ( figure 1, F and G) . Neurologic examination revealed persistent acral dysesthesias in the fingertips and weakness of intrinsic hand muscles while pain sensation improved markedly. The band-like tightening over the patient's upper abdomen resolved and may be interpreted as what has been described as a false localizing sign of her cervical myelopathy. PROMIS Global Physical Health 10 score had improved and was 13/20. The patient was scheduled for clinical reevaluation in 1 year.
Question for consideration:
1. What is your final diagnosis?
Discussion
Our diagnosis was cervical myelopathy related to spinal stenosis caused by calcinosis in the setting of systemic scleroderma (SSC). SSC is an immune-mediated rheumatic disorder characterized by dysfunction in the repair of connective tissue. Gastroesophageal reflux and Raynaud phenomenon are the most common primary manifestations. Diagnostic criteria established by the American College of Rheumatology and the European League against Rheumatism include fibrosis of the skin and internal organs, production of autoantibodies, and vasculopathy. 2 The disease is most prevalent in middle-aged women. Overall incidence is 20 per million adults per year in the United States. 3 The prognosis of SSC is determined primarily by the involvement of internal organs. Subcutaneous calcinosis typically occurs at localized sites of recurrent microtrauma such as elbows. Infrequently, SSC may affect the spinal column through dystrophic calcinosis. Neurologic complications are rare and often result from compression or entrapment of peripheral or cranial nerves. 4 We identified reports of 9 patients with soft tissue calcinosis involving the cervical spinal cord resulting in radiculopathy or myelopathy published in the last 20 years. [5] [6] [7] A single fatal case due to ectopic calcinosis compromising the cervical cord has been reported. 7 Diagnosis rests upon CT and MRI of the spine.
18
F-FDG PET/CT and SPECT can assist in the distinction from malignant processes. Treatment of SSC focuses on the reduction of symptoms. For management of the common skinassociated complications, various randomized trials revealed the benefit of immune-modulating therapies, namely methotrexate and mycophenolate mofetil. Moreover, endothelin receptor blockers, which are typically used for treatment of pulmonary hypertension, also reduce the number of digital ulcers in patients with SSC. 8 Less certain is the effect of immunomodulatory therapy on soft tissue calcinosis and overall survival. 9 At this point it is generally recommended to excise symptomatic calcinosis while asymptomatic lesions are followed expectantly. For patients with poor prognosis due to extensive organ manifestations, intensive immunosuppression or stem cell transplantation may be beneficial. 10 Our case represents an unusual neurologic complication of SSC. Soft tissue calcinosis can result in profound neurologic morbidity even in patients on immunosuppressive therapy. Modern neuroimaging facilitates timely localization and diagnosis, which serves as the basis for surgical management and restoration of neurologic function.
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